Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 150 record(s)

Req # A-2021-000384

Requesting the following information regarding medical device BLEScath Intratracheal Catheter (license no. 105680, device identifier 54-1100): The approved purpose/intended use of the device. The approved labelling. Published clinical literature that was supplied to Health Canada as a part of the medical device application, the title/citation of the articles referenced, or a copy of the literature itself.

Organization: Health Canada

3 page(s)
April 2022

Req # A-2021-000775

The Privacy Impact Assessment and/or the Privacy Compliance Evaluation that was performed regarding ArriveCAN mobile application pursuant to the Interim Directive on Privacy Impact Assessment from the Treasury Board.

Organization: Health Canada

90 page(s)
April 2022

Req # A-2021-001446

The complete list of medical cannabis research that Health Canada has been involved in since the enacting of the original Marihuana Medical Access Regularions (MMAR) legislation, through to November 26th, 2021.

Organization: Health Canada

1 page(s)
April 2022

Req # A-2021-001454

Most recent publicly available product labelling available from Health Canada including package insert, label and carton for Flon Laboratories Inc. Dehydrated Alcohol (DIN 00394394) and Hospira Healthcare ULC Dehydrated Alcohol (DIN 00537640).

Organization: Health Canada

13 page(s)
April 2022

Req # A-2021-001744

The brand name of the reference product and the dosage form of the generic submission under review for the combination of medicinal ingredients sulfamethoxazole and trimethoprim.

Organization: Health Canada

1 page(s)
April 2022

Req # A-2021-001977

The Code of Conduct for Health Canada. The Code of Conduct for employees of the Public Service Occupational Health Program. The Code of Conduct for Occupational Health Medical Officers within the Public Service Occupational Health Program.

Organization: Health Canada

25 page(s)
April 2022

Req # A-2021-002003

The Canada Gazette, Part I, Volume 155, Number 25: Order Amending Schedules 2 and 3 to the Tobacco and Vaping Products Act (Flavours) REGULATORY IMPACT ANALYSIS STATEMENT refers to the elicitation of estimates of the risk of vaping compared to smoking from five academics. The process used to elicit this information. A report on eliciting the experts' opinion, analogous to "Elicitation of Expert Judgements on the Behavioural Aspects of a Nicotine Standard" March 2017. Any report or documentation referring to how information on the risks of vaping was elicited from the five academics.

Organization: Health Canada

67 page(s)
April 2022

Req # A-2021-002004

Grants or other payments have Health Canada made to Physicians for a Smoke-Free Canada from Jan 1st, 2021 to Feb 24th, 2022. The purpose of each payment or grant. What did Health Canada receive in return for the payment or grant?

Organization: Health Canada

14 page(s)
April 2022

Req # A-2021-002020

List of the organizations, excluding sole proprietorships and partnerships, that have been distributed free rapid tests through the COVID-19 free rapid testing program from its launch, until Jan 27th, 2022

Organization: Health Canada

12 page(s)
April 2022

Req # A-2021-002066

The exact number of individuals who's deaths were reported to Health Canada in 2020 where antipsychotic medication was listed at the primary suspect. Of these deaths involving antipsychotics, the number of individuals who died from a completed suicide. The exact number of individuals who's deaths were reported to Health Canada in 2020 where antidepressant medication was listed as the primary suspect.

Organization: Health Canada

313 page(s)
April 2022
Date modified: